Mitochondrial Disease
Resources
Medications
Insurance Assistance
Forzinity
Kygevvi
Get Involved
Research
About Us
About Us
2026-2029 Strategic Plan
2025 Annual Report
Donate
Donate Now
Energy for Life
Family Tribute Pages
Match Your Gift
Get Support
UMDF Co-signs Letter Encouraging Congress to “Act Swiftly” to Reauthorize the Rare Pediatric Disease PRV Program
Mito Advocacy
,
Press Room
Last Updated:
Sep 11, 2025 @ 12:12 pm
Search for:
Categories
About Mito
Conference
Research News
Position Statements
Corporate Partner
Fundraising
Mito Champion Spotlight
Donor Spotlight
Recent Posts
Saol Therapeutics Announces Resubmission of DCA for the Treatment of PDCD
UMDF and Mito Foundation Announce 2026 Research Grant Program Award Winners
June 2026 Newsletter: Time for Mito Med 2026
May 2026 Newsletter: Support Our Spring Appeal
September 2025 Newsletter: World Mito Week, FDA News, Return of Ask The Mito Doc & Bench-to-Bedside
A Special World Mitochondrial Disease Week Message from UMDF President & CEO Kristen Clifford
Related Posts
Saol Therapeutics Announces Resubmission of DCA for th...
Read article: Saol Therapeutics Announces Resubmission of DCA for the Treatment of PDCD
UMDF and Mito Foundation Announce 2026 Research Grant ...
Read article: UMDF and Mito Foundation Announce 2026 Research Grant Program Award Winners
June 2026 Newsletter: Time for Mito Med 2026
Read article: June 2026 Newsletter: Time for Mito Med 2026
